A Fair Access Policy for the Saudi Biobank

International Journal of Research in Health Sciences,2014,2,4,945-946.
Published:October 2014
Type:Short Communication
Author(s) affiliations:

Ghiath Alahmad1, Kris Dierickx2

1-King Abdullah International Medical Research Center / King Saud bin Abdulaziz University for Health Sciences, Department of Bioethics, NGHA; Riyadh, SAUDI ARABIA.

2-Centre for Biomedical Ethics and Law, KU Leuven, Faculty of Medicine; Leuven, BELGIUM.


In recent times, an increasing number of research biobanks have been established in many parts of the world, and medical research has increased as well [1]. Getting access to large numbers of samples and data is a key factor in the development of successful research, which requires collaboration between researchers and biobanks and among biobanks themselves and pharmaceutical companies [2]. However, this is fraught with logistical difficulties and ethical challenges, especially those related to medical confidentiality. A good balance between allowing access to samples and data and conducting medical research on one hand, and preserving the rights of the participants— especially protecting the confidentiality and privacy of donors and not harming them—are key factors in the success of biobanks [3]. Read more....

A Fair Access Policy for the Saudi Biobank